Daehun Kwag
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Nosocomial Respiratory Virus Infections in Hematologic Malignancies: Risk Factors for Progression to Lower Respiratory Tract Infection.
Journal: Transplantation and cellular therapy
Published: April 24, 2026
Frontline ponatinib plus hyper-CVAD over imatinib in adults with Ph-positive acute lymphoblastic leukemia: realworld efficacy and risks of early ponatinib dose reduction.
Journal: Haematologica
Published: October 24, 2025
Donor type and post-transplant outcomes in anti-thymocyte globulin based allogeneic transplantation for myelodysplastic syndromes.
Journal: Annals of hematology
Published: October 21, 2025
Real-World Effectiveness of Recombinant Zoster Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients.
Journal: Transplantation and cellular therapy
Published: October 10, 2025
Relapse patterns focusing on central nervous system involvement after allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.
Journal: Bone marrow transplantation
Published: August 30, 2025
A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells.
Journal: Cancer research
Published: August 19, 2025
Predicting treatment-free remission after thrombopoietin receptor agonist therapy in immune thrombocytopenia: real-world outcomes from a Korean cohort.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 27, 2025
Outcomes of Haploidentical Stem Cell Transplantation in Upfront and Salvage Settings for Adult Patients with Severe Aplastic Anemia.
Journal: Transplantation and cellular therapy
Published: June 21, 2025
Real-World Outcome of Defibrotide Treatment for Severe Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: June 18, 2025
BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation.
Journal: Blood cancer journal
Published: May 20, 2025
Clinical outcomes of WHO2022 and ICC MDS entities with risk stratification by IPSS-R and IPSS-M.
Journal: Haematologica
Published: April 23, 2025
Ponatinib Monotherapy in Adult Patients with Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: A Real-World Retrospective Analysis Including Measurable Residual Disease Relapse.
Journal: Acta haematologica
Published: March 20, 2025
Last Updated: 09/26/2026